Drug intelligence / Profile preview

toluidine blue + dextran 40

Development stage
Preclinical
Modality
Small Molecules
Administration
Submucosal
01

Overview

Toluidine blue + dextran 40 (TB-Dex-40) is a lymphatic tracer agent being investigated for sentinel lymph node (SLN) detection and lymphatic mapping, particularly in head and neck cancers. The combination consists of toluidine blue (a metachromatic dye, also known as tolonium chloride) conjugated or combined with dextran-40, a low molecular weight polysaccharide. Dextran-40 acts as a macromolecular carrier that modifies the pharmacokinetic profile of the dye, reducing its diffusion at the injection site and increasing its affinity and retention time within the lymphatic system. Preclinical studies have shown that TB-Dex-40 provides significantly longer staining persistence in sentinel lymph nodes compared to toluidine blue alone, facilitating more accurate surgical identification of drainage pathways. It is designed to improve the specificity of lymphatic vessel staining and prolong the visibility of lymph nodes during surgical procedures.

Other names
toluidine blue-dextran-40tolonium chloride + dextran 40
02

Targets

Neuraminidase

Beyond the preview

Go deeper on toluidine blue + dextran 40.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on toluidine blue + dextran 40.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call